Tag: Pfizers
USFDA approves Pfizer’s Hympavzi for rare bleeding disorder hemophilia | World...
Analysts expect sales of Hympavzi to reach $300 million by 2030, according to estimates compiled by LSEG. (Photo: Reuters)2 min read...